News

CLINICAL TRIALS

The clinical trials list has been updated. See list on this link

Posted January 31, 2017

pCODR Expert Review Committee (pERC) Final Recommendation for Nivolumab in Advanced Kidney Cancer

The Health Technology Assessment review for nivolumab for advanced kidney cancer has concluded with a recommendation that nivolumab be reimbursed, conditional on pending price negotiations with the manufacturer. The pCODR recommendation provides guidance for all provinces except Quebec. pCODR report on this link.

Posted September 2, 2016

Events

Wednesday, April 5, 2017
KIDNEY CANCER INFORMATION
AND OUTREACH SESSION
Durham Region

Oshawa,Ontario, ON
Details on this link

 

Saturday, April 22, 2017
Patient & Caregiver Bilingual Forum
LIVE IT! SURVIVE IT! CURE IT!

Ottawa, ON
This year, the all-day forum will be held in English and French (simultaneous translation services will be available).
Details on this link

 

Latest Tweets

Error parsing XSLT file: \xslt\latestTweets.xslt
The Canadian Urological Association (CUA) endorses Kidney Cancer Canada and its mission; this does not necessarily equate to endorsement of this website's contents.
LinkedIn Google Plus Twitter Facebook Youtube Instagram Wordpress